Notícias · Recifes

Anticancer 'nanoswitch' technology shows promise in animal model of triple-negative breast

A research team led by Professor Yoosoo Yang (Department of Integrative Biotechnology) of Sungkyunkwan University, in collaboration with the Korea Institute of Science and Technology (KIST) and Incheon National University, has developed a next-generation anticancer immunotherapy

Admin Recifes 15/07/2026 2

Second prostate-specific membrane antigen PET scan can change treatment for nearly half of

A second prostate-specific membrane antigen (PSMA) PET scan changed treatment plans for nearly half of patients whose first scan was negative, according to new research published in the July issue of The Journal of Nuclear Medicine. Findings from the repeat PSMA scans, which incl

Admin Recifes 15/07/2026 2

Artemisinin resistance is rising in East Africa—leaving anti-malarials at risk of failure

Resistance to the main drug in front-line malaria treatments is becoming more widespread across East Africa, according to new research by Imperial College London. The study, published in The Lancet Infectious Diseases, maps the rise in artemisinin resistance in the region and sug

Admin Recifes 15/07/2026 2

Antidepressant effects seen with transcranial pulse stimulation

Prefrontal transcranial pulse stimulation is associated with antidepressant effects, according to a study published online July 6 in JAMA Network Open.

Admin Recifes 15/07/2026 2

Study finds obesity 'fuels' leukemia, but a combo using popular weight-loss drugs may stop

Obesity can act as fuel for leukemia, according to a study led by Indiana University School of Medicine scientists. To help patients facing aggressive blood cancers overcome this metabolic risk, researchers identified a potential treatment strategy that combines popular weight-lo

Admin Recifes 15/07/2026 2

Rapid magnetic brain stimulation eases depression within days, but benefits fade within we

Despite decades of advances in mental health care, depression remains one of the world's most disabling conditions. Many people with major depressive disorder (MDD) fail to find lasting relief from antidepressants or psychological therapies. Studies indicate that the global burde

Admin Recifes 15/07/2026 3

Amyloid-clearing treatment may curb tau buildup for years in Alzheimer's brain

An analysis of the brain of a deceased Alzheimer's disease (AD) clinical trial participant found that regions where an anti-amyloid therapy successfully cleared amyloid plaques showed little to no evidence of tau tangles, a hallmark of AD closely linked to neurodegeneration and c

Admin Recifes 15/07/2026 2

Genetically engineered Bifidobacterium shows potential for oral delivery of cancer vaccine

A novel oral vaccine platform using genetically engineered Bifidobacterium could enhance anti-tumor immunity. In an exploratory Phase I clinical study, the vaccine was well tolerated and generated immunologic and clinical findings that warrant further investigation. The results a

Admin Recifes 15/07/2026 2

Wearable microneedle patch tracks antibiotic levels in real time, preclinical tests show

Wearable devices have transformed how people track exercise, sleep, heart rate and other vital signs. Researchers at King Abdullah University of Science and Technology (KAUST) are now exploring whether similar technologies could one day help monitor medicines inside the body.

Admin Recifes 15/07/2026 2

Immunotherapy shows long-term promise in aggressive lymphoma

A leading-edge immunotherapy may extend survival for patients with one of the most aggressive forms of blood cancer, according to newly published five-year results from a major clinical trial in the Blood Journal. The clinical trial evaluated lisocabtagene maraleucel (liso-cel),

Admin Recifes 15/07/2026 2

Trial of potential Ebola antiviral under way: WHO

The first clinical trial of an antiviral drug's effectiveness in people exposed to the deadly Ebola strain spreading in the Democratic Republic of Congo is underway, the WHO said Tuesday.

Admin Recifes 15/07/2026 2

Is xenophobia in South Africa risking investment?

Vigilante groups and right-wing populist forces are stoking anti-immigrant sentiment and demanding that they leave the country by June 30. Experts fear serious economic implications for the country and the region.

Admin Recifes 15/07/2026 2

Acompanhe as Notícias da Recifes